Acute Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
2021-11-15
Nov 15, 2021
D
Recruiting
  • Acute Myelogenous Leukemia
  • Boston, Massachusetts
  • +1 more
2021-11-15
Nov 15, 2021
N
Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
2021-11-11
Nov 11, 2021
N
Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
2021-11-11
Nov 11, 2021
N
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
2021-10-29
Oct 29, 2021
N
Active, not recruiting
  • Mucopolysaccharidosis I
  • +15 more
  • Human Placental Derived Stem Cell
  • Denver, Colorado
  • +2 more
2021-10-29
Oct 29, 2021
U
Active, not recruiting
  • Leukemia
  • +2 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
2021-10-28
Oct 28, 2021
M
Completed
  • Acute Myelogenous Leukemia
  • +4 more
  • Single Umbilical Cord Blood Unit Transplant
  • +6 more
  • Birmingham, Alabama
  • +37 more
2021-10-13
Oct 13, 2021
N
Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-23
    Oct 23, 2021
    C
    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +3 more
    2021-10-19
    Oct 19, 2021
    V
    Active, not recruiting
    • Hodgkin's Lymphoma
    • +17 more
    • mycophenolate mofetil
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    2021-10-14
    Oct 14, 2021
    T
    Not yet recruiting
    • Myelofibrosis
    • Acute Myelogenous Leukemia
    • TBX-2400
    • Zagreb, Croatia
    • +1 more
    2021-10-04
    Oct 4, 2021
    M
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Rochester, Minnesota
    • +1 more
    2021-09-21
    Sep 21, 2021
    X
    Recruiting
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    2021-09-21
    Sep 21, 2021
    G
    Active, not recruiting
    • High-risk Myelodysplastic Syndromes
    • +3 more
    • GTB-3550 TriKE® Phase I
    • GTB-3550 TriKE® Phase II
    • Minneapolis, Minnesota
    • +1 more
    2021-09-15
    Sep 15, 2021
    T
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Los Angeles, California
    • +32 more
    2021-09-07
    Sep 7, 2021
    A
    Active, not recruiting
    • Acute Myelogenous Leukemia
    • +2 more
    • Duarte, California
    • +22 more
    2021-09-01
    Sep 1, 2021
    W
    Recruiting
    • Acute Myelogenous Leukemia
    • +4 more
    • Stem cell transplantation
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    2021-09-01
    Sep 1, 2021
    N
    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    2021-08-30
    Aug 30, 2021
    C
    Recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +8 more
    2021-08-30
    Aug 30, 2021
    M
    Recruiting
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +8 more
    2021-08-23
    Aug 23, 2021
    E
    Recruiting
    • Myeloid Leukemia, Chronic
    • +8 more
    • Conventional T cells (Tcon) and Regulatory T cells (Treg)
    • Palo Alto, California
      Stanford University School of Medicine Palo Alto, California, Un
    2021-08-18
    Aug 18, 2021